Evolus, Inc.: insider trading
241 trades by 22 directors, officers and 10% owners since 2018, from their SEC Form 4 and 5 filings.
Bought, 12 months
$0
0 purchases by 0 insiders
Sold, 12 months
$1.8 M
7 sales by 2 insiders
Bought, 3 months
$0
0 purchases
Sold, 3 months
$950 K
1 sale
Insider buying and selling by month
Open-market purchases and sales by value, last three years.
Insiders (22)
Each insider's latest direct holding and their open-market trades of the last 12 months, most recent first.
| Insider | Shares owned directly | Bought, 12 m | Sold, 12 m | Latest trade |
|---|---|---|---|---|
| David MoatazediSee Remarks, Director | 499,592 | — | $1.7 M | |
| Rui AvelarSee Remarks | 427,423 | — | $178 K | |
| Albert G. White IIIDirector | 95,937 | — | — | |
| Brady StewartDirector | 134,188 | — | — | |
| David N. GillDirector | 86,887 | — | — | |
| Karah Herdman ParschauerDirector | 77,742 | — | — | |
| Tatjana MitchellChief Financial Officer | 226,092 | — | — | |
| Vikram MalikDirector | 321,109 | — | — | |
| Tomoko Yamagishi-DresslerChief Marketing Officer | 89,949 | — | — | |
| Sandra BeaverChief Financial Officer | 167,089 | — | — | |
| Simone BlankDirector | 77,111 | — | — | |
| Robert HaymanDirector | 54,856 | — | — | |
| Medytox Inc.Former 10% Owner | 3.38 M | — | — | |
| Alphaeon 1 LLC10% owner | 4.21 M | — | — | |
| Peter C. FarrellDirector | 43,174 | — | — | |
| Lauren P. SilvernailSee Remarks | 141,571 | — | — | |
| Crystal MuilenburgChief Marketing Officer | 134,248 | — | — | |
| Michael M. JafarSee Remarks | 219,851 | — | — | |
| AEON Biopharma, Inc.Former 10% Owner | 0 | — | — | |
| Alphaeon Corp10% owner | 8.66 M | — | — | |
| Kristine RomineDirector | 80,909 | — | — | |
| Bosun HauDirector | 10,040 | — | — |
Trades#
| Traded | Insider | Trade | Shares | Price | Value | Owned after | Filing |
|---|---|---|---|---|---|---|---|
| filed | David MoatazediSee Remarks, Director | Sell | -105,108 | $9.040 | $950 K | 499,592 | Form 4 |
| filed | Rui AvelarSee Remarks | Sell10b5-1 plan | -3,119 | $4.750 | $15 K | 427,423 | Form 4 |
| filed | David MoatazediSee Remarks, Director | Sell10b5-1 plan | -13,669 | $4.750 | $65 K | 604,700 | Form 4 |
| filed | David MoatazediSee Remarks, Director | Sell10b5-1 plan | -116,720 | $4.890 | $571 K | 618,369 | Form 4 |
| filed | Rui AvelarSee Remarks | Sell10b5-1 plan | -29,996 | $4.890 | $147 K | 430,542 | Form 4 |
| filed | David MoatazediSee Remarks, Director | Option exercise10b5-1 plan | +67,489 | — | — | 735,089 | Form 4 |
| filed | Rui AvelarSee Remarks | Option exercise10b5-1 plan | +8,804 | — | — | 460,538 | Form 4 |
| filed | Vikram MalikDirector | Grant or award | +45,559 | — | — | 321,109 | Form 4 |
| filed | Karah Herdman ParschauerDirector | Grant or award | +45,559 | — | — | 77,742 | Form 4 |
| filed | David N. GillDirector | Grant or award | +45,559 | — | — | 86,887 | Form 4 |
| filed | David MoatazediSee Remarks, Director | Grant or award | +313,212 | — | — | 667,600 | Form 4 |
| filed | Tatjana MitchellChief Financial Officer | Grant or award | +121,489 | — | — | 226,092 | Form 4 |
| filed | Brady StewartDirector | Grant or award | +45,559 | — | — | 134,188 | Form 4 |
| filed | Albert G. White IIIDirector | Grant or award | +45,559 | — | — | 95,937 | Form 4 |
| filed | Rui AvelarSee Remarks | Grant or award | +94,913 | — | — | 451,734 | Form 4 |
| filed | David MoatazediSee Remarks, Director | Sell10b5-1 plan | -10,539 | $7.150 | $75 K | 354,388 | Form 4 |
| filed | Rui AvelarSee Remarks | Sell10b5-1 plan | -2,261 | $7.150 | $16 K | 356,821 | Form 4 |
| filed | Tatjana MitchellChief Financial Officer | Grant or award | +104,603 | — | — | 104,603 | Form 4 |
| filed | Tomoko Yamagishi-DresslerChief Marketing Officer | Sell10b5-1 plan | -5,722 | $7.510 | $43 K | 89,949 | Form 4 |
| filed | Brady StewartDirector | Buy | +30,000 | $6.820 | $205 K | 88,629 | Form 4 |
| filed | David MoatazediSee Remarks, Director | Sell | -16,582 | $9.890 | $164 K | 364,927 | Form 4 |
| filed | David MoatazediSee Remarks, Director | Sell | -111,323 | $10.05 | $1.1 M | 381,509 | Form 4 |
| filed | Albert G. White IIIDirector | Buy | +20,000 | $9.450 | $189 K | 50,378 | Form 4 |
| filed | Sandra BeaverChief Financial Officer | Sell10b5-1 plan | -6,494 | $10.02 | $65 K | 167,089 | Form 4 |
| filed | David MoatazediSee Remarks, Director | Sell10b5-1 plan | -15,787 | $9.870 | $156 K | 492,832 | Form 4 |
| filed | Rui AvelarSee Remarks | Sell10b5-1 plan | -3,385 | $9.870 | $33 K | 359,082 | Form 4 |
| filed | David MoatazediSee Remarks, Director | Sell10b5-1 plan | -6,251 | $12.40 | $78 K | 508,619 | Form 4 |
| filed | Rui AvelarSee Remarks | Sell10b5-1 plan | -27,904 | $13.26 | $370 K | 362,467 | Form 4 |
| filed | Tomoko Yamagishi-DresslerChief Marketing Officer | Sell10b5-1 plan | -4,536 | $13.26 | $60 K | 95,671 | Form 4 |
| filed | Sandra BeaverChief Financial Officer | Sell10b5-1 plan | -8,996 | $13.26 | $119 K | 173,583 | Form 4 |
| filed | David MoatazediSee Remarks, Director | Sell10b5-1 plan | -103,376 | $13.26 | $1.4 M | 514,870 | Form 4 |
| filed | Karah Herdman ParschauerDirector | Sell | -12,888 | $12.99 | $167 K | 32,183 | Form 4 |
| filed | David N. GillDirector | Grant or award | +7,364 | — | — | 41,328 | Form 4 |
| filed | Albert G. White IIIDirector | Grant or award | +7,364 | — | — | 30,378 | Form 4 |
| filed | Karah Herdman ParschauerDirector | Grant or award | +7,364 | — | — | 45,071 | Form 4 |
| filed | Simone BlankDirector | Grant or award | +7,364 | — | — | 77,111 | Form 4 |
| filed | Tomoko Yamagishi-DresslerChief Marketing Officer | Grant or award | +17,832 | — | — | 100,207 | Form 4 |
| filed | Vikram MalikDirector | Grant or award | +7,364 | — | — | 253,878 | Form 4 |
| filed | Sandra BeaverChief Financial Officer | Grant or award | +35,663 | — | — | 182,579 | Form 4 |
| filed | Rui AvelarSee Remarks | Grant or award | +23,776 | — | — | 390,371 | Form 4 |
| filed | David MoatazediSee Remarks, Director | Grant or award | +95,399 | — | — | 618,246 | Form 4 |
| filed | Brady StewartDirector | Grant or award | +7,364 | — | — | 58,629 | Form 4 |
| filed | Sandra BeaverChief Financial Officer | Sell10b5-1 plan | -1,586 | $10.85 | $17 K | 146,916 | Form 4 |
| filed | David MoatazediSee Remarks, Director | Sell10b5-1 plan | -10,502 | $10.85 | $114 K | 522,847 | Form 4 |
| filed | Rui AvelarSee Remarks | Sell10b5-1 plan | -2,252 | $10.85 | $24 K | 366,595 | Form 4 |
| filed | Sandra BeaverChief Financial Officer | Sell | -3,276 | $14.98 | $49 K | 148,502 | Form 4 |
| filed | Tomoko Yamagishi-DresslerChief Marketing Officer | Sell | -5,631 | $15.85 | $89 K | 82,375 | Form 4 |
| filed | Albert G. White IIIDirector | Grant or award | +23,014 | — | — | 23,014 | Form 4 |
| filed | David MoatazediSee Remarks, Director | Option exercise | +175,940 | $7.280 | $1.3 M | 709,289 | Form 4 |
| filed | David MoatazediSee Remarks, Director | Sell | -175,940 | $12.59 | $2.2 M | 533,349 | Form 4 |
| filed | David MoatazediSee Remarks, Director | Option exercise | +155,278 | $5.460 | $848 K | 688,627 | Form 4 |
| filed | David MoatazediSee Remarks, Director | Sell | -155,278 | $12.92 | $2.0 M | 533,349 | Form 4 |
| filed | David MoatazediSee Remarks, Director | Sell | -140,214 | $12.73 | $1.8 M | 533,349 | Form 4 |
| filed | Vikram MalikDirector | Sell | -7,500 | $12.96 | $97 K | 246,514 | Form 4 |
| filed | David N. GillDirector | Sell | -6,718 | $12.60 | $85 K | 33,964 | Form 4 |
| filed | David N. GillDirector | Sell | -3,643 | $12.72 | $46 K | 40,682 | Form 4 |
| filed | Vikram MalikDirector | Sell | -28,000 | $12.93 | $362 K | 254,014 | Form 4 |
| filed | Sandra BeaverChief Financial Officer | Sell | -2,423 | $12.72 | $31 K | 151,778 | Form 4 |
| filed | David MoatazediSee Remarks, Director | Sell | -16,051 | $12.72 | $204 K | 673,563 | Form 4 |
| filed | Rui AvelarSee Remarks | Sell | -3,441 | $12.72 | $44 K | 368,847 | Form 4 |
| filed | David MoatazediSee Remarks, Director | Sell | -6,236 | $13.86 | $86 K | 689,614 | Form 4 |
| filed | David MoatazediSee Remarks, Director | Sell | -96,566 | $13.92 | $1.3 M | 695,850 | Form 4 |
| filed | Sandra BeaverChief Financial Officer | Sell | -5,672 | $13.92 | $79 K | 154,201 | Form 4 |
| filed | Rui AvelarSee Remarks | Sell | -27,603 | $13.92 | $384 K | 372,288 | Form 4 |
| filed | Sandra BeaverChief Financial Officer | Sell10b5-1 plan | -1,821 | $13.08 | $24 K | 159,873 | Form 4 |
| filed | David MoatazediSee Remarks, Director | Sell10b5-1 plan | -7,706 | $13.08 | $101 K | 792,416 | Form 4 |
| filed | Rui AvelarSee Remarks | Sell10b5-1 plan | -1,821 | $13.08 | — | 399,891 | Form 4 |
| filed | Sandra BeaverChief Financial Officer | Grant or award10b5-1 plan | +13,115 | — | — | 161,694 | Form 4 |
| filed | Rui AvelarSee Remarks | Grant or award10b5-1 plan | +13,115 | — | — | 401,712 | Form 4 |
| filed | David MoatazediSee Remarks, Director | Grant or award10b5-1 plan | +61,202 | — | — | 800,122 | Form 4 |
| filed | Karah Herdman ParschauerDirector | Grant or award | +6,464 | — | — | 37,707 | Form 4 |
| filed | David MoatazediSee Remarks, Director | Grant or award | +134,976 | — | — | 738,920 | Form 4 |
| filed | David N. GillDirector | Grant or award | +6,464 | — | — | 44,325 | Form 4 |
| filed | Sandra BeaverChief Financial Officer | Grant or award | +35,211 | — | — | 148,579 | Form 4 |
| filed | Brady StewartDirector | Grant or award | +6,464 | — | — | 51,265 | Form 4 |
| filed | Vikram MalikDirector | Grant or award | +6,464 | — | — | 282,014 | Form 4 |
| filed | Tomoko Yamagishi-DresslerChief Marketing Officer | Grant or award | +24,648 | — | — | 24,648 | Form 4 |
| filed | Simone BlankDirector | Grant or award | +6,464 | — | — | 69,747 | Form 4 |
| filed | Robert HaymanDirector | Grant or award | +6,464 | — | — | 54,856 | Form 4 |
| filed | Rui AvelarSee Remarks | Grant or award | +35,211 | — | — | 388,597 | Form 4 |
| filed | Karah Herdman ParschauerDirector | Sell10b5-1 plan | -11,931 | $13.14 | $157 K | 31,243 | Form 4 |
| filed | David MoatazediSee Remarks, Director | Sell | -31,300 | $9.730 | $305 K | 603,944 | Form 4 |
| filed | David MoatazediSee Remarks, Director | Sell | -51,348 | $10.09 | $518 K | 635,244 | Form 4 |
| filed | Medytox Inc.Former 10% Owner | Sell | -1.69 M | $7.500 | $12.7 M | 3.38 M | Form 4 |
| filed | Sandra BeaverChief Financial Officer | Sell10b5-1 plan | -3,178 | $9.700 | $31 K | 113,368 | Form 4 |
| filed | Tomoko Yamagishi-DresslerChief Marketing Officer | Grant or award | +63,358 | — | — | 63,358 | Form 4 |
| filed | Sandra BeaverChief Financial Officer | Sell10b5-1 plan | -2,211 | $10.27 | $23 K | 116,546 | Form 4 |
| filed | David MoatazediSee Remarks, Director | Sell10b5-1 plan | -14,778 | $10.27 | $152 K | 686,592 | Form 4 |
| filed | Rui AvelarSee Remarks | Sell10b5-1 plan | -2,211 | $10.27 | — | 353,386 | Form 4 |
| filed | Vikram MalikDirector | Buy | +174,967 | $7.410 | $1.3 M | 275,550 | Form 4 |
| filed | Sandra BeaverChief Financial Officer | Grant or award10b5-1 plan | +19,672 | — | — | 118,757 | Form 4 |
| filed | Rui AvelarSee Remarks | Grant or award10b5-1 plan | +19,672 | — | — | 355,597 | Form 4 |
| filed | David MoatazediSee Remarks, Director | Grant or award10b5-1 plan | +91,803 | — | — | 701,370 | Form 4 |
| filed | Vikram MalikDirector | Other | +22,998 | — | — | 100,583 | Form 4 |
| filed | Robert HaymanDirector | Other | +218 | — | — | 48,392 | Form 4 |
| filed | Simone BlankDirector | Other | +109 | — | — | 63,283 | Form 4 |
| filed | Robert HaymanDirector | Otherindirect | +366 | — | — | 10,366 | Form 4 |
| filed | Simone BlankDirector | Otherindirect | +115,206 | — | — | 482,783 | Form 4 |
| filed | David MoatazediSee Remarks, Director | Sell10b5-1 plan | -6,110 | $8.470 | $52 K | 609,567 | Form 4 |
| filed | Rui AvelarSee Remarks | Sell10b5-1 plan | -14,906 | $8.470 | $126 K | 335,925 | Form 4 |
| filed | David MoatazediSee Remarks, Director | Sell10b5-1 plan | -64,211 | $8.470 | $544 K | 615,677 | Form 4 |
| filed | Alphaeon 1 LLC10% owner | Sell | -1.85 M | $8.400 | $15.5 M | 4.21 M | Form 4 |
| filed | Medytox Inc.10% owner | Sell | -2.19 M | $8.500 | $18.6 M | 5.07 M | Form 4 |
| filed | Simone BlankDirector | Grant or award | +8,293 | — | — | 63,174 | Form 4 |
| filed | Peter C. FarrellDirector | Grant or award | +8,293 | — | — | 43,174 | Form 4 |
| filed | David N. GillDirector | Grant or award | +8,293 | — | — | 37,861 | Form 4 |
| filed | Brady StewartDirector | Grant or award | +8,293 | — | — | 44,801 | Form 4 |
| filed | Robert HaymanDirector | Grant or award | +8,293 | — | — | 48,174 | Form 4 |
| filed | Vikram MalikDirector | Grant or award | +8,293 | — | — | 77,585 | Form 4 |
| filed | Karah Herdman ParschauerDirector | Grant or award | +8,293 | — | — | 43,174 | Form 4 |
| filed | Sandra BeaverChief Financial Officer | Grant or award | +62,642 | — | — | 99,085 | Form 4 |
| filed | Rui AvelarSee Remarks | Grant or award | +97,642 | — | — | 350,831 | Form 4 |
| filed | David MoatazediSee Remarks, Director | Grant or award | +187,927 | — | — | 679,888 | Form 4 |
| filed | Medytox Inc.10% owner | Sellindirect | -37,043 | $11.04 | $409 K | 7.26 M | Form 4 |
| filed | Medytox Inc.10% owner | Sell | -38,304 | $8.990 | $344 K | 7.26 M | Form 4 |
| filed | Medytox Inc.10% owner | Sell | -6,848 | $8.950 | $61 K | 7.30 M | Form 4 |
| filed | Medytox Inc.10% owner | Sell | -24,000 | $10.34 | $248 K | 7.30 M | Form 4 |
| filed | Medytox Inc.10% owner | Sell | -73,000 | $10.27 | $750 K | 7.33 M | Form 4 |
| filed | Robert HaymanDirector | Buyindirect | +1,091 | $10.78 | $12 K | 10,000 | Form 4 |
| filed | Robert HaymanDirector | Buyindirect | +8,909 | $10.35 | $92 K | 8,909 | Form 4 |
| filed | Medytox Inc.10% owner | Sell | -20,700 | $10.53 | $218 K | 7.40 M | Form 4 |
| filed | Medytox Inc.10% owner | Sell | -15,300 | $10.39 | $159 K | 7.42 M | Form 4 |
| filed | Robert HaymanDirector | Buyamended | +5,000 | $10.05 | $50 K | 39,881 | Form 4/A |
| filed | Robert HaymanDirector | Buy | +4,967 | $10.05 | $50 K | 39,848 | Form 4 |
| filed | Simone BlankDirector | Buy | +20,000 | $9.240 | $185 K | 54,881 | Form 4 |
| filed | Peter C. FarrellDirector | Buyindirect | +10,000 | $9.100 | $91 K | 10,000 | Form 4 |
| filed | Sandra BeaverChief Financial Officer | Grant or award | +36,443 | — | — | 36,443 | Form 4 |
| filed | Medytox Inc.10% owner | Sell | -26,000 | $13.28 | $345 K | 7.44 M | Form 4 |
| filed | Lauren P. SilvernailSee Remarks | Sell | -52,015 | $12.42 | $646 K | 141,571 | Form 4 |
| filed | Lauren P. SilvernailSee Remarks | Sell | -16,189 | $13.92 | $225 K | 193,586 | Form 4 |
| filed | David MoatazediSee Remarks, Director | Sell | -55,321 | $13.64 | $755 K | 491,961 | Form 4 |
| filed | David N. GillDirector | Sell | -5,000 | $13.62 | $68 K | 29,568 | Form 4 |
| filed | David N. GillDirector | Sell | -5,313 | $13.10 | $70 K | 34,568 | Form 4 |
| filed | David MoatazediSee Remarks, Director | Sell10b5-1 plan | -6,104 | $11.62 | $71 K | 547,282 | Form 4 |
| filed | Crystal MuilenburgChief Marketing Officer | Sell10b5-1 plan | -6,495 | $9.730 | $63 K | 134,248 | Form 4 |
| filed | Lauren P. SilvernailSee Remarks | Sell10b5-1 plan | -10,192 | $9.730 | $99 K | 209,775 | Form 4 |
| filed | David MoatazediSee Remarks, Director | Sell10b5-1 plan | -37,972 | $9.730 | $369 K | 553,386 | Form 4 |
| filed | Rui AvelarSee Remarks | Sell10b5-1 plan | -10,192 | $9.730 | — | 253,189 | Form 4 |
| filed | David N. GillDirector | Grant or award | +15,568 | — | — | 39,881 | Form 4 |
| filed | Lauren P. SilvernailSee Remarks | Grant or award | +53,571 | — | — | 219,967 | Form 4 |
| filed | Vikram MalikDirector | Grant or award | +15,568 | — | — | 69,292 | Form 4 |
| filed | Robert HaymanDirector | Grant or award | +15,568 | — | — | 34,881 | Form 4 |
| filed | Karah Herdman ParschauerDirector | Grant or award | +15,568 | — | — | 34,881 | Form 4 |
| filed | Rui AvelarSee Remarks | Grant or award | +53,571 | — | — | 263,381 | Form 4 |
| filed | Simone BlankDirector | Grant or award | +15,568 | — | — | 34,881 | Form 4 |
| filed | David MoatazediSee Remarks, Director | Grant or award | +214,286 | — | — | 591,358 | Form 4 |
| filed | Crystal MuilenburgChief Marketing Officer | Grant or award | +50,000 | — | — | 140,743 | Form 4 |
| filed | Peter C. FarrellDirector | Grant or award | +15,568 | — | — | 34,881 | Form 4 |
| filed | Brady StewartDirector | Grant or award | +36,508 | — | — | 36,508 | Form 4 |
| filed | Alphaeon 1 LLC10% owner | Sell | -2.60 M | $9.500 | $24.7 M | 6.06 M | Form 4 |
| filed | Medytox Inc.10% owner | Buy | +51,000 | $10.93 | $557 K | 7.46 M | Form 4 |
| filed | Medytox Inc.10% owner | Buy | +66,000 | $11.02 | $727 K | 7.41 M | Form 4 |
| filed | Medytox Inc.10% owner | Buy | +44,000 | $11.12 | $489 K | 7.35 M | Form 4 |
| filed | Medytox Inc.10% owner | Buy | +72,219 | $11.17 | $807 K | 7.30 M | Form 4 |
| filed | Medytox Inc.10% owner | Buy | +69,781 | $11.03 | $770 K | 7.23 M | Form 4 |
| filed | Vikram MalikDirector | Sellindirect | -26,077 | $11.00 | $287 K | 1.14 M | Form 4 |
| filed | Medytox Inc.10% owner | Buy | +48,000 | $10.56 | $507 K | 7.16 M | Form 4 |
| filed | Vikram MalikDirector | Sellindirect | -49,878 | $10.61 | $529 K | 1.17 M | Form 4 |
| filed | Medytox Inc.10% owner | Buy | +55,000 | $10.51 | $578 K | 7.11 M | Form 4 |
| filed | Vikram MalikDirector | Sellindirect | -11,962 | $10.50 | $126 K | 1.22 M | Form 4 |
| filed | Medytox Inc.10% owner | Buy | +45,000 | $10.54 | $474 K | 7.06 M | Form 4 |
| filed | Vikram MalikDirector | Sellindirect | -25,000 | $10.44 | $261 K | 1.23 M | Form 4 |
| filed | Vikram MalikDirector | Sellindirect | -42,083 | $10.06 | $423 K | 1.26 M | Form 4 |
| filed | Medytox Inc.10% owner | Buy | +70,000 | $10.69 | $748 K | 7.01 M | Form 4 |
| filed | David MoatazediSee Remarks, Director | Sell | -47,737 | $11.35 | $542 K | 377,072 | Form 4 |
| filed | Medytox Inc.10% owner | Buy | +65,000 | $11.34 | $737 K | 6.94 M | Form 4 |
| filed | Medytox Inc.10% owner | Buyindirect | +14,043 | $11.11 | $156 K | 7.30 M | Form 4 |
| filed | Medytox Inc.10% owner | Buy | +49,714 | $10.98 | $546 K | 6.88 M | Form 4 |
| filed | David MoatazediSee Remarks, Director | Sell | -22,708 | $10.66 | $242 K | 424,809 | Form 4 |
| filed | Medytox Inc.10% owner | Buyindirect | +23,000 | $10.99 | $253 K | 7.28 M | Form 4 |
| filed | Medytox Inc.10% owner | Buy | +39,126 | $10.93 | $428 K | 6.83 M | Form 4 |
| filed | Medytox Inc.10% owner | Buy | +26,160 | $10.77 | $282 K | 6.79 M | Form 4 |
| filed | Lauren P. SilvernailSee Remarks | Sell10b5-1 plan · amended | -14,293 | $11.18 | — | 166,396 | Form 4/A |
| filed | David MoatazediSee Remarks, Director | Sell10b5-1 plan · amended | -41,763 | $11.18 | $467 K | 447,517 | Form 4/A |
| filed | Crystal MuilenburgChief Marketing Officer | Sell10b5-1 plan | +5,362 | $11.18 | $60 K | 101,467 | Form 4 |
| filed | Crystal MuilenburgChief Marketing Officer | Sell10b5-1 plan · amended | -5,362 | $11.18 | $60 K | 90,743 | Form 4/A |
| filed | Rui AvelarSee Remarks | Sell10b5-1 plan | -14,293 | $11.18 | $160 K | 209,810 | Form 4 |
| filed | David MoatazediSee Remarks, Director | Sell10b5-1 plan | +41,763 | $11.18 | $467 K | 531,043 | Form 4 |
| filed | Lauren P. SilvernailSee Remarks | Sell10b5-1 plan | +14,293 | $11.18 | — | 194,982 | Form 4 |
| filed | Vikram MalikDirector | Grant or award | +18,011 | — | — | 53,724 | Form 4 |
| filed | David MoatazediSee Remarks, Director | Grant or award | +48,853 | — | — | 489,280 | Form 4 |
| filed | Simone BlankDirector | Grant or award | +19,313 | — | — | 19,313 | Form 4 |
| filed | Peter C. FarrellDirector | Grant or award | +19,313 | — | — | 19,313 | Form 4 |
| filed | Robert HaymanDirector | Grant or award | +19,313 | — | — | 19,313 | Form 4 |
| filed | David N. GillDirector | Grant or award | +19,313 | — | — | 24,313 | Form 4 |
| filed | Vikram MalikDirector | Grant or award | +19,313 | — | — | 35,713 | Form 4 |
| filed | Karah Herdman ParschauerDirector | Grant or award | +19,313 | — | — | 19,313 | Form 4 |
| filed | Michael M. JafarSee Remarks | Grant or award | +45,000 | — | — | 219,851 | Form 4 |
| filed | Rui AvelarSee Remarks | Grant or award | +90,000 | — | — | 224,103 | Form 4 |
| filed | Lauren P. SilvernailSee Remarks | Grant or award | +90,000 | — | — | 180,689 | Form 4 |
| filed | David MoatazediSee Remarks, Director | Grant or award | +266,667 | — | — | 440,427 | Form 4 |
| filed | Rui AvelarSee Remarks | Sell10b5-1 plan | -2,699 | $7.460 | $20 K | 134,103 | Form 4 |
| filed | David MoatazediSee Remarks, Director | Sell10b5-1 plan | -8,310 | $7.460 | $62 K | 173,760 | Form 4 |
| filed | Michael M. JafarSee Remarks | Sell10b5-1 plan | -2,699 | $7.460 | — | 174,851 | Form 4 |
| filed | Lauren P. SilvernailSee Remarks | Sell10b5-1 plan | -2,699 | $7.460 | — | 90,689 | Form 4 |
| filed | Michael M. JafarSee Remarks | Grant or award | +48,550 | — | — | 177,550 | Form 4 |
| filed | David MoatazediSee Remarks, Director | Grant or award | +100,000 | — | — | 182,070 | Form 4 |
| filed | Rui AvelarSee Remarks | Grant or award | +40,000 | — | — | 136,802 | Form 4 |
| filed | Michael M. JafarChief Marketing Officer | Grant or award | +40,000 | — | — | 129,000 | Form 4 |
| filed | Lauren P. SilvernailSee Remarks | Grant or award | +40,000 | — | — | 93,388 | Form 4 |
| filed | Rui AvelarSee Remarks | Grant or award | +26,000 | — | — | 96,802 | Form 4 |
| filed | Michael M. JafarChief Marketing Officer | Grant or award | +26,000 | — | — | 89,000 | Form 4 |
| filed | Lauren P. SilvernailSee Remarks | Grant or award | +26,000 | — | — | 53,388 | Form 4 |
| filed | David MoatazediSee Remarks, Director | Grant or award | +82,070 | — | — | 82,070 | Form 4 |
| filed | AEON Biopharma, Inc.Former 10% Owner | Other | -8.66 M | — | — | 0 | Form 4 |
| filed | Rui AvelarSee Remarks | Sell10b5-1 plan | -39,442 | $10.71 | $422 K | 70,802 | Form 4 |
| filed | Rui AvelarSee Remarks | Option exercise | +10,020 | $9.980 | $100 K | 110,244 | Form 4 |
| filed | David N. GillDirector | Buy | +2,000 | $13.65 | $27 K | 5,000 | Form 4 |
| filed | Vikram MalikDirector | Buyindirect | +1.30 M | $19.25 | $25.0 M | 1.30 M | Form 4 |
| filed | Alphaeon Corp10% owner | Sellamended | -1.30 M | $19.25 | $25.0 M | 8.66 M | Form 4/A |
| filed | Alphaeon Corp10% owner | Sell | -1.30 M | $19.25 | $25.0 M | 8.66 M | Form 4 |
| filed | Lauren P. SilvernailSee Remarks | Sell | -2,612 | $13.53 | $35 K | 27,388 | Form 4 |
| filed | Kristine RomineDirector | Buyindirect | +2,090 | $14.77 | $31 K | 3,450 | Form 4 |
| filed | Alphaeon Corp10% owner | Sell | -290,518 | $19.25 | $5.6 M | 9.96 M | Form 4 |
| filed | Simone BlankDirector | Buyindirect | +628,536 | $19.25 | $12.1 M | 923,560 | Form 4 |
| filed | Alphaeon Corp10% owner | Sell | -4.00 M | $19.25 | $77.0 M | 11.27 M | Form 4 |
| filed | Kristine RomineDirector | Buy | +40,562 | $19.25 | $781 K | 80,909 | Form 4 |
| filed | Alphaeon Corp10% owner | Sell | -1.02 M | $19.25 | $19.6 M | 10.25 M | Form 4 |
| filed | Vikram MalikDirector | Buy | +7,800 | $13.04 | $102 K | 16,400 | Form 4 |
| filed | Kristine RomineDirector | Buy | +5,000 | $12.75 | $64 K | 40,347 | Form 4 |
| filed | David N. GillDirector | Buy | +3,000 | $12.77 | $38 K | 3,000 | Form 4 |
| filed | Kristine RomineDirector | Buy | +11,000 | $12.50 | $138 K | 35,347 | Form 4 |
| filed | Alphaeon Corp10% owner | Sell | -573,888 | $14.00 | $8.0 M | 15.27 M | Form 4 |
| filed | Simone BlankDirector | Buyindirect | +295,024 | $14.00 | $4.1 M | 295,024 | Form 4 |
| filed | Kristine RomineDirector | Buy | +6,347 | $14.00 | $89 K | 24,347 | Form 4 |
| filed | Michael M. JafarChief Marketing Officer | Buy | +12,800 | $20.83 | $267 K | 63,000 | Form 4 |
| filed | Alphaeon Corp10% owner | Sell | -1.75 M | $21.04 | $36.8 M | 15.84 M | Form 4 |
| filed | Kristine RomineDirector | Buy | +10,000 | $19.83 | $198 K | 18,000 | Form 4 |
| filed | Kristine RomineDirector | Grant or awardindirect | +160 | $19.98 | $3 K | 1,360 | Form 4 |
| filed | Alphaeon Corp10% owner | Sell | -1.00 M | $18.80 | $18.8 M | 17.59 M | Form 4 |
| filed | Michael M. JafarChief Marketing Officer | Grant or award | +50,000 | — | — | 50,200 | Form 4 |
| filed | Vikram MalikDirector | Buy | +8,600 | $28.88 | $248 K | 8,600 | Form 4 |
| filed | Kristine RomineDirector | Buy | +2,000 | $28.05 | $56 K | 8,000 | Form 4 |
| filed | Kristine RomineDirector | Buyindirect | +200 | $33.40 | $7 K | 1,200 | Form 4 |
| filed | Bosun HauDirector | Buy | +2,898 | $34.94 | $101 K | 10,040 | Form 4 |
| filed | Bosun HauDirector | Buy | +7,142 | $29.19 | $208 K | 7,142 | Form 4 |
| filed | Kristine RomineDirector | Buy | +4,000 | $25.74 | $103 K | 6,000 | Form 4 |
| filed | Kristine RomineDirector | Buy | +2,000 | $24.40 | $49 K | 2,000 | Form 4 |
| filed | Kristine RomineDirector | Buyindirect | +1,000 | $24.40 | $24 K | 2,000 | Form 4 |
| filed | Lauren P. SilvernailSee Remarks | Grant or award | +30,000 | — | — | 30,000 | Form 4 |
| filed | Alphaeon Corp10% owner | Conversion | +2.07 M | — | — | 2.07 M | Form 4 |